Grace Therapeutics (L8S.F) Q4 2025 Earnings

13NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.36
-0.21
-0.06
0.09

Details

Expected EPS
-0.21600687999999998
Actual EPS
-0.051594
Surprise EPS
0.16
Surprise Percent
+76.11%

Description

Grace Therapeutics (L8S.F) has reported earnings of -0.051594 per share for Q4 2025.

0 Comments

Share your thoughts